Stay updated on Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial

Sign up to get notified when there's something new on the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6. This reflects a new revision/version of the page content but does not alter the study details themselves.
    Difference
    0.1%
    Check dated 2026-08-30T15:34:05.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.6.4 to v3.6.5, indicating a new version of the page. This reflects a maintenance update rather than a substantive change to the study information.
    Difference
    0.1%
    Check dated 2026-08-08T23:35:00.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, replacing the previous revision. This appears to be a metadata update with no changes to the displayed study details.
    Difference
    0.1%
    Check dated 2026-07-25T12:55:44.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page's Revision field was updated to v3.6.3, replacing the previous v3.6.2.
    Difference
    0.1%
    Check dated 2026-07-03T23:50:08.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.6.2, replacing the previous v3.6.0. This represents a routine site update rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-06-27T00:14:08.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    The page now indicates recruitment is closed and adds user guidance sections; the Intervention/Treatment header formatting is updated, and the site revision is shown as v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:30:40.000Z thumbnail image

Stay in the know with updates to Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page.